Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001246101 | SCV001419439 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-10-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln521*) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with limb-girdle muscular dystrophy (PMID: 28403181). ClinVar contains an entry for this variant (Variation ID: 970519). For these reasons, this variant has been classified as Pathogenic. |
3billion, |
RCV001246101 | SCV002058362 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-01-03 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS).The variant has been reported to be associated with CAPN3 related disorder (ClinVar ID: VCV000970519, PMID:28403181). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Baylor Genetics | RCV003462825 | SCV004213810 | pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2023-01-26 | flagged submission | clinical testing |